Patent · US Active

Immunoglobulins

US8362208B2 · kind B2 · utility

0Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2006
Grant dateJan 29, 2013
Priority date
Expiry dateNov 24, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/565
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to antibodies to NOGO, pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.